Cargando…

Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD

INTRODUCTION: Soluble urokinase-type plasminogen activator receptor (suPAR) is upregulated by inflammation and plays a role in the pathogenesis of atherosclerosis. Chronic obstructive pulmonary disease (COPD) is associated with enhanced systemic inflammation and increased risk for atherosclerosis, h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Böcskei, Renáta M., Benczúr, Béla, Losonczy, György, Illyés, Miklós, Cziráki, Attila, Müller, Veronika, Bohács, Anikó, Bikov, András
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	COPD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486892/ https://www.ncbi.nlm.nih.gov/pubmed/30820636 http://dx.doi.org/10.1007/s00408-019-00211-w

Ejemplares similares

Oscillometrically Measured Aortic Pulse Wave Velocity Reveals Asymptomatic Carotid Atherosclerosis in a Middle-Aged, Apparently Healthy Population
por: Böcskei, Renáta Marietta, et al.
Publicado: (2020)

Relationship of Circulating Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels to Disease Control in Asthma and Asthmatic Pregnancy
por: Ivancsó, István, et al.
Publicado: (2013)

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study
por: Kardos, Peter, et al.
Publicado: (2020)

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea
por: Bocskei, Renata Marietta, et al.
Publicado: (2020)

Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study
por: Morjaria, Jaymin B., et al.
Publicado: (2017)

Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
por: Pini, Laura, et al.
Publicado: (2022)

Continuous Cough Monitoring Using Ambient Sound Recording During Convalescence from a COPD Exacerbation
por: Crooks, Michael G., et al.
Publicado: (2017)

Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD
por: Jabbal, Sunny, et al.
Publicado: (2017)

Circulating survivin levels in healthy and asthmatic pregnancy
por: Bikov, Andras, et al.
Publicado: (2014)

Determining Static Hyperinflation in Patients with Severe Emphysema: Relation Between Lung Function Parameters and Patient-Related Outcomes
por: de Weger, Wouter W., et al.
Publicado: (2020)

Risk of Readmission and Mortality Following Hospitalization with Hypercapnic Respiratory Failure
por: Meservey, Amber J., et al.
Publicado: (2019)

IL-8 Gene Variants and Expression in Childhood Asthma
por: Charrad, Rihab, et al.
Publicado: (2017)

Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Chen, Zhixiang, et al.
Publicado: (2022)

Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations
por: Crooks, Michael G., et al.
Publicado: (2021)

Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers
por: Yang, Lucy, et al.
Publicado: (2017)

Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
por: Godtfredsen, Nina S., et al.
Publicado: (2018)

Circulating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy
por: Dombai, Brigitta, et al.
Publicado: (2017)

Decreased Serum Sirtuin-1 in COPD
por: Yanagisawa, Satoru, et al.
Publicado: (2017)

Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses
por: Csoma, Balázs, et al.
Publicado: (2021)

Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD
por: Footitt, Joseph, et al.
Publicado: (2016)

Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review
por: Tabyshova, Aizhamal, et al.
Publicado: (2021)

Clinical Consequences of COVID-19 Lockdown in Patients With COPD: Results of a Pre-Post Study in Spain
por: González, Jessica, et al.
Publicado: (2021)

The Relationship Between Cough Reflex Sensitivity and Exacerbation Frequency in Chronic Obstructive Pulmonary Disease
por: Cho, Peter S. P., et al.
Publicado: (2020)

Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD
por: Gumus, Aziz, et al.
Publicado: (2015)

Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD
por: AboEl-Magd, Gehan Hassan, et al.
Publicado: (2018)

Asthma in pregnancy - from immunology to clinical management
por: Tamási, Lilla, et al.
Publicado: (2010)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients
por: Lin, Wei-Chen, et al.
Publicado: (2023)

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
por: Haastrup, Eva, et al.
Publicado: (2014)

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia
por: van Oort, Pouline M., et al.
Publicado: (2019)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor level in individuals of advanced age
por: Wlazel, Rafal N., et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022)

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD
por: Csoma, Balázs, et al.
Publicado: (2019)

Surface markers of lymphocyte activation in pregnant asthmatics
por: Bohács, Anikó, et al.
Publicado: (2009)

The Clinical Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Autoimmune Connective Tissue Disorders
por: Vasarhelyi, Barna, et al.
Publicado: (2016)

Elevation of serum urokinase plasminogen activator receptor and liver stiffness in postoperative biliary atresia
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2016)

Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
por: Wittenhagen, Per, et al.
Publicado: (2011)

A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
por: Spinale, Joann M., et al.
Publicado: (2014)

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
por: Erkut, Nergiz, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sff2ha8kt4a4t2b6rjtof63s3f